The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers
- Conditions
- Clostridium DifficileColitis
- Registration Number
- NCT02063282
- Lead Sponsor
- Amos Yinnon
- Brief Summary
The investigators hypothesize that development of symptoms characteristic of Clostridium difficile infection will be 2-3 times higher in asymptomatic carriers, compared to that of non carriers and expect to find risk factors for development of symptomatic clostridium difficile.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 394
- History of hospitalization in recent year, residence of a nursing home or institutions
- Expected more than 48 hours hospitalization
- Colitis/ diarrhea
- Rectal swab performed ≥48 hrs post arrival to hospital.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Development of colitis Daily follow-up participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
Patients' file will be reviewed and the next signs and symptoms will be recorded: abdominal pain, diarrhea, fever and leukocytosis.
- Secondary Outcome Measures
Name Time Method Duration until development of colitis Daily follow-up participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
Patients' file will be reviewed and the next signs and symptoms will be recorded: abdominal pain, diarrhea, fever and leukocytosis.Severity of colitis Daily follow-up participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
Patients' file will be reviewed and the next signs and symptoms will be recorded: abdominal pain, diarrhea, fever and leukocytosis.
Trial Locations
- Locations (1)
Shaare Zedek Medical Center
🇮🇱Jerusalem, Israel
Shaare Zedek Medical Center🇮🇱Jerusalem, Israel